These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 34280810

  • 1. CRISPR/Cas9-based inactivation of human papillomavirus oncogenes E6 or E7 induces senescence in cervical cancer cells.
    Inturi R, Jemth P.
    Virology; 2021 Oct; 562():92-102. PubMed ID: 34280810
    [Abstract] [Full Text] [Related]

  • 2. Gene Targeting of HPV18 E6 and E7 Synchronously by Nonviral Transfection of CRISPR/Cas9 System in Cervical Cancer.
    Ling K, Yang L, Yang N, Chen M, Wang Y, Liang S, Li Y, Jiang L, Yan P, Liang Z.
    Hum Gene Ther; 2020 Mar; 31(5-6):297-308. PubMed ID: 31989837
    [Abstract] [Full Text] [Related]

  • 3. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC, DiMaio D.
    Proc Natl Acad Sci U S A; 2000 Nov 07; 97(23):12513-8. PubMed ID: 11070078
    [Abstract] [Full Text] [Related]

  • 4. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
    Kennedy EM, Kornepati AV, Goldstein M, Bogerd HP, Poling BC, Whisnant AW, Kastan MB, Cullen BR.
    J Virol; 2014 Oct 07; 88(20):11965-72. PubMed ID: 25100830
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y, Jiang H, Wang T, He D, Tian R, Cui Z, Tian X, Gao Q, Ma X, Yang J, Wu J, Tan S, Xu H, Tang X, Wang Y, Yu Z, Han H, Das BC, Severinov K, Hitzeroth II, Debata PR, Xu W, Fan W, Jin Z, Cao C, Yu M, Xie W, Huang Z, Hu Z, You Z.
    Antiviral Res; 2020 Jun 07; 178():104794. PubMed ID: 32298665
    [Abstract] [Full Text] [Related]

  • 6. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, Xu G, Meng L, Lu Y, Wang S, Ma D.
    Apoptosis; 2008 Feb 07; 13(2):273-81. PubMed ID: 18060502
    [Abstract] [Full Text] [Related]

  • 7. Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA.
    Lee CJ, Suh EJ, Kang HT, Im JS, Um SJ, Park JS, Hwang ES.
    Exp Cell Res; 2002 Jul 15; 277(2):173-82. PubMed ID: 12083799
    [Abstract] [Full Text] [Related]

  • 8. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
    von Knebel Doeberitz M, Rittmüller C, Aengeneyndt F, Jansen-Dürr P, Spitkovsky D.
    J Virol; 1994 May 15; 68(5):2811-21. PubMed ID: 8151752
    [Abstract] [Full Text] [Related]

  • 9. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells.
    Honegger A, Leitz J, Bulkescher J, Hoppe-Seyler K, Hoppe-Seyler F.
    Int J Cancer; 2013 Oct 01; 133(7):1631-42. PubMed ID: 23526637
    [Abstract] [Full Text] [Related]

  • 10. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
    Fujii T, Saito M, Iwasaki E, Ochiya T, Takei Y, Hayashi S, Ono A, Hirao N, Nakamura M, Kubushiro K, Tsukazaki K, Aoki D.
    Int J Oncol; 2006 Sep 01; 29(3):541-8. PubMed ID: 16865269
    [Abstract] [Full Text] [Related]

  • 11. Antiproliferative effects of AAV-delivered CRISPR/Cas9-based degradation of the HPV18-E6 gene in HeLa cells.
    Noroozi Z, Shamsara M, Valipour E, Esfandyari S, Ehghaghi A, Monfaredan A, Azizi Z, Motevaseli E, Modarressi MH.
    Sci Rep; 2022 Feb 09; 12(1):2224. PubMed ID: 35140292
    [Abstract] [Full Text] [Related]

  • 12. Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells.
    Psyrri A, DeFilippis RA, Edwards AP, Yates KE, Manuelidis L, DiMaio D.
    Cancer Res; 2004 May 01; 64(9):3079-86. PubMed ID: 15126344
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis.
    Shin MK, Balsitis S, Brake T, Lambert PF.
    Cancer Res; 2009 Jul 15; 69(14):5656-63. PubMed ID: 19584294
    [Abstract] [Full Text] [Related]

  • 14. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N, Wang S, Wang W, Kong D, Xu Q, Tian X, Luo A, Zhou J, Xu G, Meng L, Lu Y, Ma D.
    Gynecol Oncol; 2007 Aug 15; 106(2):299-304. PubMed ID: 17586029
    [Abstract] [Full Text] [Related]

  • 15. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.
    Honegger A, Schilling D, Bastian S, Sponagel J, Kuryshev V, Sültmann H, Scheffner M, Hoppe-Seyler K, Hoppe-Seyler F.
    PLoS Pathog; 2015 Mar 15; 11(3):e1004712. PubMed ID: 25760330
    [Abstract] [Full Text] [Related]

  • 16. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.
    Sanduja S, Kaza V, Dixon DA.
    Aging (Albany NY); 2009 Sep 10; 1(9):803-17. PubMed ID: 20157568
    [Abstract] [Full Text] [Related]

  • 17. HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer.
    Yu L, Majerciak V, Lobanov A, Mirza S, Band V, Liu H, Cam M, Hughes SH, Lowy DR, Zheng Z-M.
    mBio; 2024 May 08; 15(5):e0072924. PubMed ID: 38624210
    [Abstract] [Full Text] [Related]

  • 18. Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells.
    Bai L, Wei L, Wang J, Li X, He P.
    Int J Gynecol Cancer; 2006 May 08; 16(2):718-29. PubMed ID: 16681752
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly.
    Boon SS, Chen Z, Li J, Lee KYC, Cai L, Zhong R, Chan PKS.
    BMC Cancer; 2019 Dec 12; 19(1):1211. PubMed ID: 31830929
    [Abstract] [Full Text] [Related]

  • 20. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
    Lee K, Lee AY, Kwon YK, Kwon H.
    Biochem Biophys Res Commun; 2011 Aug 26; 412(2):328-33. PubMed ID: 21821000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.